Protalix BioTherapeutics awarded insider Elze Christian 25,500 derivative securities across two transactions on 2026-09-03 at $0 per share. After those transactions, Christian owned 8,500 derivative securities in Protalix BioTherapeutics, giving investors the disclosed post-transaction position in the company’s insider activity to track.

Key Highlights

  • The transactions occurred on 3 September 2026, with each carrying SEC transaction code A.
  • Elze Christian’s post-transaction holding was 8,500 derivative securities.
  • The transactions were reported at $0 per share.

Protalix BioTherapeutics, Inc. (AMEX: PLX) awarded insider Elze Christian 25,500 derivative securities across two transactions. The securities were awarded to Christian, who is identified as an insider of Protalix BioTherapeutics.

on September 3 The transactions took place on 3 September 2026. Both used SEC transaction code A, and the recorded price was $0 per share. After the transactions, Christian owned 8,500 derivative securities of Protalix BioTherapeutics.